Seeking Alpha

Yu2014

Yu2014
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Don't look now, but momentum stock Intercept Pharma is rallying again [View news story]
    You should buy Genfit / ALGFT instead. Its GTF505 product hasn't any side-effects and seems efficient (see preclinical and clinical results). End of phase 2b = october 2014.
    Genfit is still very much undervalued.
    Feb 28, 2014. 11:05 AM | Likes Like |Link to Comment
  • Pharmaceutical Stocks Continue To Act Well [View instapost]
    Hello,

    I’m a french shareholder of Genfit, and I totally agree with your last sentence. I think that Genfit is far too undervalued if one considers the valuation of Intercept, the size of the NASH market, and the advantages that the GFT505 has over Intercept’s product.

    GFT505 has been proven to have no important side-effects : http://bit.ly/1fPDL6a
    That’s not the case for the Intercept’s product.

    As for the efficiency of GFT505, the 2b phase will end in October, 2014. The preclinical and the first clinical results seem to prove that it has great effects on multiple NASH factors. See that and that :
    http://bit.ly/LD5wFZ
    http://bit.ly/1dxLQKC

    Besides, one information that you may not have is that Genfit CEO, Jean-François Mouney, recently stated in a French interview that some American funds have been buying a lot of shares (10%-15% of the whole company, end of January) :
    http://bit.ly/1b2EiV7
    “Nos interlocuteurs font aujourd’hui partie du top 10 des investisseurs dans le domaine des biotechnologies, ce qui était encore difficile il y a un an. Notre visibilité a fait un bond en avant. J’ai été informé de l’entrée significative à notre capital de quelques fonds américains. Et nous pensons aujourd’hui que ces investisseurs américains représentent déjà de l’ordre de 10 à 15% du capital de Genfit en moins de trois semaines. “

    One additional information that you may not have is that Jean-François Mouney recently said that Genfit will be, by the end of spring, transferred from Alternext (French small caps market) to Euronext. It will greatly improve visibility, liquidity, … for investors.

    Sincerely yours,

    Yu
    Feb 26, 2014. 02:53 AM | Likes Like |Link to Comment
COMMENTS STATS
2 Comments
0 Likes